1. Home
  2. ARTL vs NCL Comparison

ARTL vs NCL Comparison

Compare ARTL & NCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$5.86

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Logo Northann Corp.

NCL

Northann Corp.

HOLD

Current Price

$0.16

Market Cap

3.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTL
NCL
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.7M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ARTL
NCL
Price
$5.86
$0.16
Analyst Decision
Hold
Analyst Count
2
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.9M
327.8K
Earning Date
05-12-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.43
EPS
N/A
N/A
Revenue
N/A
$15,349,854.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.86
52 Week Low
$0.85
$0.10
52 Week High
$28.60
$1.47

Technical Indicators

Market Signals
Indicator
ARTL
NCL
Relative Strength Index (RSI) 50.95 50.87
Support Level $2.24 $0.14
Resistance Level $6.16 $0.17
Average True Range (ATR) 2.41 0.02
MACD -0.28 0.00
Stochastic Oscillator 17.37 78.99

Price Performance

Historical Comparison
ARTL
NCL

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About NCL Northann Corp.

Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. It offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, mainly through its sales network in North America and Europe.

Share on Social Networks: